TrialRheumatology international2024

Exploring TNFi drug-levels and anti-drug antibodies during tapering among patients with inflammatory arthritis: secondary analyses from the randomised BIODOPT trial.

Line Uhrenholt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.